News
The HHS terminated funding for for Moderna's avian influenza vaccine due to safety concerns with mRNA vaccines.
HHS previously awarded $176 million for a mRNA-based vaccine against the H5N1 avian influenza. Moderna, Inc. received notice ...
With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.
2d
Investing News Network on MSNBird Flu Vaccine Stocks: 8 Companies Developing H5N1 VaccinesLife science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 ...
The federal government should be investing and working to expand the nation’s scientific and public health arsenal, not shrinking it.
On May 28, the U.S. Department of Health and Human Services (HHS) canceled a $590 million contract to Moderna, a ...
OHIO — The Department of Health and Human Services canceled funding for the development of vaccine meant to protect humans from avian influenza. “Yeah, I think they’re watching this with skepticism,” ...
The U.S. Department of Health and Human Services has canceled its $776 million contract with Moderna to develop an mRNA-based ...
HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...
Zoetis received conditional USDA approval for an avian flu vaccine. Major poultry and dairy organizations back vaccine use to control the virus. The Trump administration is rolling out a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results